Delivery Order SPE2DB20D3303-SPE2DB25FA3DK
- Not listed
- The Defense Logistics Agency awarded a $2,187.36 delivery order to AmerisourceBergen Drug Corp for the supply of Januvia 100 mg tablets (90-count) on August 29, 2025, with an ultimate completion date of September 2, 2025. This firm fixed-price, non-set-aside contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The prime vendor agreement serves as a...
- The Defense Logistics Agency awarded a $2,182.92 firm fixed price delivery order to AmerisourceBergen Drug Corp on September 2, 2025, for the supply of Januvia 50 mg tablets (90-count units). The contract, which represents a non-set-aside competitive award, will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of September 3, 2025. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a $5,882.70 firm fixed-price delivery order to AmerisourceBergen Drug Corp on July 22, 2025, for the supply of Januvia 50 mg tablets (90-count packages). The contract, with an ultimate completion date of July 23, 2025, represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.999 billion comprehensive pharmaceutical support vehicle running through December 2026. This...
- The Defense Logistics Agency awarded a $5,078.66 delivery order to AmerisourceBergen Drug Corp on August 8, 2025, for the supply of Januvia 100 mg tablets (90-count units). This is a firm fixed price, competitively awarded contract with no set-aside designation and an ultimate completion date of August 11, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is executed under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $2,182.92 to AmerisourceBergen Drug Corp for the supply of Januvia 100 mg tablets (90-count packages) on August 13, 2025, with an ultimate completion date of August 14, 2025. This firm fixed price delivery order was competitively awarded with no set-aside designation and is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,637.19 to AmerisourceBergen Drug Corp for the supply of Januvia 50 mg tablets (90-count package) on August 25, 2025, with an ultimate completion date of August 26, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and is being fulfilled from the vendor's place of performance in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen Drug Corp's larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of Januvia 100 mg tablets (90-count units) with a ceiling value of $2,201.40. This firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The award was competitively awarded with no set-aside...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of Januvia 50 mg tablets (90-count units) valued at $8,972.46 under a firm fixed-price contract structure. This non-set-aside award represents a child delivery order executed against AmerisourceBergen's larger pharmaceutical supply vehicle. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its...
- The Defense Logistics Agency awarded a $2,182.92 firm fixed-price delivery order to AmerisourceBergen Drug Corp on August 15, 2025, for the supply of Januvia 100 mg tablets (90-count units). The contract, which is not set-aside and was competitively awarded, calls for performance completion by August 18, 2025, with fulfillment at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a $3,416.79 delivery order to AmerisourceBergen Drug Corp on July 23, 2025, for the supply of Januvia 100 mg tablets (90-count units). This non-set-aside, competitively awarded contract represents a firm fixed price delivery order with performance at the contractor's Conshohocken, Pennsylvania location and an ultimate completion date of July 24, 2025. The award falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- SPE2DB20D3303Indefinite Delivery Contract
- SPE2DB20D3303-SPE2DB25FA3DKDelivery Order
The Defense Logistics Agency awarded a $2,587.68 delivery order to AmerisourceBergen Drug Corp on September 2, 2025, for the supply of Januvia 50 mg tablets (quantity: 90-count packages). This firm fixed-price delivery order, with an ultimate completion date of September 3, 2025, represents a competitively awarded, non-set-aside contract with performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract is a child award issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical procurement vendor, serves as a prime contractor for the Defense Logistics Agency's Medical Supply Chain, providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare systems. The SPE2DX IDC functions as a global pharmaceutical support vehicle enabling the company to supply specialty medications, brand-name and generic drugs, vaccines, and medical supplies across multiple therapeutic domains to customers including the Defense Health Agency and U.S. Coast Guard. This delivery order for Januvia, a diabetes medication, reflects the company's extensive portfolio of pharmaceutical deliveries through competitively awarded contracts demonstrating capability to meet federal healthcare requirements.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.6k | 9/2/25 |